Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-27 10:52:11 - browse：664

Illustration of the U.S. made of blue and white lines. -- health tech coverage from STAT — Adobe

A group of academic hospitals and technology companies will form a new nonprofit venture to oversee a nationwide network of laboratories to test artificial intelligence tools designed for use in health care.

The nonprofit will establish the laboratories at Mayo Clinic, Duke, Stanford, and other major universities and institutions around the country. Its goal is to create a system to certify and register AI models, and publish details about their performance before they are widely adopted. The labs are expected to begin operating within the next few months.

The nonprofit’s launch, unfolding amid rapid innovation and investment in AI, is an attempt at industry self-policing as increasingly powerful — and opaque — algorithmic models begin making their way into medical settings. It is being formed by a group known as the Coalition for Health AI, whose leadership includes technology experts at the academic hospitals that would host the testing labs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Healthy food access boosts outcomes in two studies

focus

WSS

Experimental asthma app from Apple and Anthem shows promise

Publishing genetic code of viruses could cause disaster

What health policies could hitch a ride on a spending bill?

NIH chief: government has fallen behind pharma on clinical trials

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Living organ donors deserve priority status for transplants

leisure time

Wikipedia

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Millions may soon lose Medicaid when they don't have to

Medicare proposal to cover medical devices draws a mixed reaction

Xenotransplantation trials will require adjusting expectations, experts say

Psychedelics group wrestles with new pharma identity

The thinking behind the controversial eating disorder chatbot Tessa

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Zepbound, Valneva's vaccine, and more

How one medical school became remarkably diverse

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

entertainment

Can medical device makers keep up in the race to treat obesity?

Mom launches Girl Scout troop for LGBTQ youth in Texas

Readout Newsletter: Zepbound, Valneva's vaccine, and more

A letter from the executive editor: STAT UnitedHealth investigation

Millions may soon lose Medicaid when they don't have to

After decades in use, heart stents finally beat placebo

focus

focus

focus

entertainment